Showing results (1791-1800 of 2,084) with videos related to
Sort By:
Pageof 209
Nature|October 18, 2011
RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol IIMikel Zaratiegui, Stephane E Castel, Danielle V Irvine, et al.Arthritis Care & Research|August 18, 2012
Efficacy of a multidisciplinary fibromyalgia treatment adapted for women with low educational levels: a randomized controlled trialAntoni Castel, Ramon Fontova, Salvador Montull, et al.Data in Brief|November 23, 2016
Data on clinical characteristics of a heart failure patients' cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNPM Batlle, B Campos, M Farrero, et al.Infectious Diseases (London, England)|March 3, 2023
Heart transplantation as salvage treatment of intractable infective endocarditisPierre Tattevin, Patricia Muñoz, Asuncion Moreno, et al.Diabetes|November 20, 2012
Gliotransmission and brain glucose sensing: critical role of endozepinesDamien Lanfray, Sébastien Arthaud, Johanne Ouellet, et al.Malaria Journal|May 8, 2019
Quality of malaria services offered in public health facilities in three provinces of Mozambique: a cross-sectional studyBaltazar Candrinho, Mateusz M Plucinski, James M Colborn, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 14, 2015
Sorting through the lost and found: are patient perceptions of engagement in care consistent with standard continuum of care measures?Amanda D Castel, Wenze Tang, James Peterson, et al.Antimicrobial Agents and Chemotherapy|August 9, 2021
Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant TuberculosisPrecious Ngwalero, James C M Brust, Stijn W van Beek, et al.Cancer|July 2, 2003
The correlation between patient characteristics and expectations of benefit from Phase I clinical trialsKevin P Weinfurt, Liana D Castel, Yun Li, et al.Cancers|October 20, 2018
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 TrialNikolai Siebert, Sascha Troschke-Meurer, Madlen Marx, et al.Pageof 209